In individuals with a history of asbestos exposure, a serum SPP1 level above 48.3 ng/mL yields a sensitivity of 77.6% and a specificity of 85.5% for diagnosing mesothelioma, with even higher accuracy observed in patients with stage I disease. This evidence concerns the gene SPP1 and mesothelioma.